Loading…
ARS Pharma develops patient-friendly therapies that reduce needle-related risks and improve portability and ease of use. Its flagship product neffy is an epinephrine nasal spray, marketed as the first and only FDA-approved needle-free epinephrine product. The company provides savings and support programs for patients and caregivers and offers resources such as neffyConnect and prescribing information.
AI named ARS Pharma from January 2026 to February 2026.